Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001571049-17-002518
Filing Date
2017-03-17
Accepted
2017-03-17 06:03:06
Documents
6
Effectiveness Date
2017-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1700770_8k.htm DEFA14A 53440
2 EXHIBIT 2.1 t1700770_ex2-1.htm EX-2.1 577741
3 EXHIBIT 10.1 t1700770_ex10-1.htm EX-10.1 66790
4 EXHIBIT 10.2 t1700770_ex10-2.htm EX-10.2 66218
5 EXHIBIT 99.1 t1700770_ex99-1.htm EX-99.1 68491
6 EXHIBIT 99.2 t1700770_ex99-2.htm EX-99.2 16458
  Complete submission text file 0001571049-17-002518.txt   850471
Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33650 | Film No.: 17696264
SIC: 8090 Services-Misc Health & Allied Services, NEC